Tropicamide

Mydriacyl (tropicamide) is a small molecule pharmaceutical. Tropicamide was first approved as Mydriacyl on 1982-01-01. It is used to treat iridocyclitis, iritis, and keratitis in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M3. In addition, it is known to target muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M4, and muscarinic acetylcholine receptor M5.